The Ozempic workout: How gyms and trainers are catering to a new group of exercisers

GLP-1 drugs such as Wegovy, Ozempic, Zepbound and Mounjaro have helped millions of people combat type 2 diabetes and cardiovascular disease as well as shed weight. The class of drugs—GLP-1 receptor agonists—has been around for two decades as a diabetes medication. Their popularity as a tool for weight loss skyrocketed after the FDA approved Wegovy for weight management in 2021.